FDA Press Release Policy Restricts Free Speech, Needs Revision – PhRMA

FDA should reconsider its policies restricting language in press releases on unapproved drug uses in light of First Amendment rights, the Pharmaceutical Research & Manufacturers of America maintains in comments to the agency